Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors

Gili Kenet*, Uri Martinowitz

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science